Stellar Biotechnologies Reports Third Quarter 2016 Financial Results and Operational Highlights
09. August 2016 08:00 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - Aug 9, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH),...
Stellar Biotechnologies Announces Third Quarter 2016 Corporate Update Conference Call
04. August 2016 08:30 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - Aug 4, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin...
Stellar Biotechnologies and Neovacs Announce Formation of New Company Neostell S.A.S. in France
19. Juli 2016 08:00 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA and PARIS, FRANCE and BOSTON, MA--(Marketwired - Jul 19, 2016) - Stellar Biotechnologies, Inc. ("Stellar") (NASDAQ: SBOT) and Neovacs S.A. ("Neovacs") (Alternext Paris: ALNEV) today...
Stellar Biotechnologies Announces Closing of Registered Direct Offering
06. Juli 2016 12:00 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - Jul 6, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin...
Stellar Biotechnologies Announces Pricing of $6.75 Million Registered Direct Offering
30. Juni 2016 08:45 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - Jun 30, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin...
Stellar Biotechnologies to Present at LD Micro Invitational Conference
02. Juni 2016 08:00 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - Jun 2, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"),...
Stellar Biotechnologies Named as a 2016 California Small Business of the Year
25. Mai 2016 09:00 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - May 25, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "Company") (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"),...
Stellar Biotechnologies Appoints Michael L. Klein, Ph.D. as Vice President of Chemistry, Manufacturing and Controls (CMC)
23. Mai 2016 08:30 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - May 23, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "Company") (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"),...
Stellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines With Stellar KLH(TM)
11. Mai 2016 10:02 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA and PARIS, FRANCE and BOSTON, MA--(Marketwired - May 11, 2016) - Stellar Biotechnologies, Inc. ("Stellar") (NASDAQ: SBOT) and Neovacs S.A. ("Neovacs") (Alternext Paris: ALNEV)...
Stellar Biotechnologies Reports Second Quarter 2016 Financial Results and Operational Highlights
09. Mai 2016 17:18 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - May 9, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin...